Ronald C. Renaud JR - Insider Trading & Ownership

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Summary
The estimated net worth of Ronald C. Renaud JR is at least $12.3K dollars as of August 5, 2024. Ronald C. Renaud JR is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $12.3K.
All Insider Reports
All Insider Reports

Ownership of Ronald C. Renaud JR

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ATRA Atara Biotherapeutics, Inc. Director $12.3K Jun 23, 2022
CERE Cerevel Therapeutics Holdings, Inc. President & CEO, Director $0 Aug 1, 2024
IKNA Ikena Oncology, Inc. Director Jun 9, 2022
TBIO Translate Bio, Inc. Chief Executive Officer, Director Sep 14, 2021

Insider Transactions Reported by Ronald C. Renaud JR:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.